Fox Chase Cancer Center Proudly Supports Miles for Melanoma Philadelphia

PHILADELPHIA (August 23, 2018) – As part of its ongoing commitment to community health, Fox Chase Cancer Center is pleased to support Miles for Melanoma 2018 in Philadelphia. Faculty and staff, volunteers, patients, survivors, and their families will come together at this family-friendly 5K run/walk to raise funds to support melanoma research, education, and advocacy through the Melanoma Research Foundation. The run/walk starts at 8 A.M. at the Philadelphia Zoo on Saturday, September 8. Check-in and registration begin at 7:00 A.M.

“I am proud to represent Fox Chase as a team captain to help promote the Melanoma Research Foundation’s efforts in melanoma research, education, and advocacy,” said Jeffrey M. Farma, MD, chief of general surgery and co-director of the Melanoma Program at Fox Chase. 

For more information about Miles for Melanoma Philadelphia, to register to join the Fox Chase team on race day, or to make a donation, visit

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427